NBT
AXDX

Northwest Bank & Trust’s Accelerate Diagnostics AXDX Stock Holding History

Northwest Bank & Trust’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$231 Hold
140
– – ﹤0.01% 194
2024
Q3 		$239 Hold
140
– – ﹤0.01% 199
2024
Q2 		$162 Hold
140
– – ﹤0.01% 200
2024
Q1 		$123 Hold
140
– – ﹤0.01% 190
2023
Q4 		$548 Buy
+140
New +$741 ﹤0.01% 192
2023
Q2 		$1.13K Buy
+140
New +$1.05K ﹤0.01% 189

Other funds holding AXDX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CS
Cannell & Spears New York $5.62B AUM 41.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BAM
Belpointe Asset Management Reno, Nevada $3.06B AUM 23.82% 1-Year Est. Return
TWA
TCI Wealth Advisors Tucson, Arizona $2.31B AUM 26.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Northwest Bank & Trust's AXDX Position: Q4 2024 in Review

Northwest Bank & Trust held its Accelerate Diagnostics (AXDX) position steady in Q4 2024 at 140 shares worth $231. The position accounts for ﹤0.01% of the portfolio, ranked #194.

Northwest Bank & Trust first reported a position in AXDX in Q2 2023 and has held it in 6 quarters since. The position peaked at $1.13K in Q2 2023. 47 funds tracked by Wall St. Rank hold AXDX as of Q4 2024.

  • Northwest Bank & Trust held 140 shares of Accelerate Diagnostics worth $231 as of Q4 2024.
  • Northwest Bank & Trust left its Accelerate Diagnostics share count unchanged in Q4 2024.
  • Accelerate Diagnostics made up ﹤0.01% of Northwest Bank & Trust's portfolio in Q4 2024, its #194 holding.
  • Northwest Bank & Trust first reported a position in Accelerate Diagnostics in Q2 2023 and has held it in 6 quarters since.
  • Northwest Bank & Trust's Accelerate Diagnostics position peaked at $1.13K in Q2 2023.
  • 47 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q4 2024.

Based on Northwest Bank & Trust's 13F filing for Q4 2024, filed 18 Feb 2025.